Search Results

The Binding Site Human Transferrin Kit is intended for the quantitative determination of human transferrin using the Binding Site SPAPLus turbidimetric analyzer in human serum. The measurement of transferrin levels aids in the diagnosis of malnutrition, acute inflammation, infection and iron deficiency anemia. This test should be used in conjunction with other laboratory and clinical findings

Not Found

The provided document is a 510(k) clearance letter from the FDA for a diagnostic kit, specifically "Human Transferrin kit for use on the SPAPlus™". This type of document primarily confirms that a new device is substantially equivalent to a legally marketed predicate device, and it typically does not include detailed study reports with specific acceptance criteria, performance data, or details about training and test sets in the way that would be provided for an AI/ML medical device submission.

The information requested in the prompt (acceptance criteria, sample sizes, ground truth establishment, expert qualifications, adjudication methods, MRMC studies, standalone performance, etc.) is characteristic of the rigorous clinical validation studies required for AI/ML devices, not typically for a traditional in vitro diagnostic kit like the one described here.

Therefore, I cannot extract the requested information from the provided text because the document does not contain details about:

• A table of acceptance criteria and reported device performance in the context of an AI/ML device. The "performance" mentioned for this kit would usually refer to analytical performance characteristics (e.g., accuracy, precision, linearity) which are not detailed here.
• Sample sizes for test sets or data provenance.
• Number of experts or their qualifications.
• Adjudication methods.
• MRMC comparative effectiveness studies.
• Standalone performance (as it's not an AI/ML algorithm).
• Type of ground truth used (beyond implying the "gold standard" for transferrin measurement).
• Sample size for training sets.
• How ground truth for training was established.

The document is a regulatory approval letter, specifically stating the device's substantial equivalence and its intended use for the quantitative determination of human transferrin to aid in the diagnosis of malnutrition, acute inflammation, infection, and iron deficiency anemia using the Binding Site SPAPlus™ turbidimetric analyzer.

Ask a specific question about this device